Sabrina Fox-Bosetti, MPH joined Sonoma Biotherapeutics from Merck, where she served as an Associate Principal Scientist in Translational Pharmacology and Vaccines research. She managed Phase 1 to Phase 2b/PoC studies and programs across the portfolio while serving on the early-stage operations leadership team. Fox-Bosetti also executed experimental medicine trials in many therapeutic areas to support clinical development programs using biomarkers to accelerate decision making.
Prior to this, Fox-Bosetti was a research associate at UCSF and assisted with the initiation of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), an effort to unite researchers around the world with study data as they work to define the diagnosis and progression of Alzheimer’s disease.
She received her undergraduate degree from the University of California at Berkeley and her MPH from Columbia University.